Canopy Growth Reports 7% YoY Drop In Q3 Revenue, CEO Touts 'New Era' For Company As It Seeks US Listing
Canopy Growth Reports 7% YoY Drop In Q3 Revenue, CEO Touts 'New Era' For Company As It Seeks US Listing
Canopy Growth报告第三季度收入同比下降7％，首席执行官在寻求美国上市时吹捧公司将迎来 “新时代”
Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) announced its financial results on Friday for the third quarter ended Dec. 31, 2023, reporting an 81% year-over-year increase in "rest-of-world" cannabis revenue to CA$10.5 million ($7.8 million).
Canopy Growth Corporation（多伦多证券交易所股票代码：WEED）（纳斯达克股票代码：CGC）周五公布了截至2023年12月31日的第三季度财务业绩，“世界其他地区” 的大麻收入同比增长81％，至1,050万加元（合780万美元）。
The Ontario, Canada-based medical cannabis giant attributed the increase in international cannabis revenue mostly to continued strong growth in Australia and a return to growth in Europe driven by new products and improved sales execution.
这家总部位于加拿大安大略省的医用大麻巨头将国际大麻收入的增长主要归因于澳大利亚持续的强劲增长，以及欧洲在新产品和销售执行改善的推动下恢复增长。
See also: These 2 Canadian Cannabis Companies Forge Ahead In European Markets With German, Dutch Ventures
另见：这两家加拿大大麻公司与德国、荷兰的合资企业一起在欧洲市场向前迈进
Canopy also revealed its plans to take its fair share of the U.S...
Canopy还透露了通过其在...
登录免费看全文
登录/注册